153 related articles for article (PubMed ID: 7761472)
1. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.
Tavernier J; Tuypens T; Verhee A; Plaetinck G; Devos R; Van der Heyden J; Guisez Y; Oefner C
Proc Natl Acad Sci U S A; 1995 May; 92(11):5194-8. PubMed ID: 7761472
[TBL] [Abstract][Full Text] [Related]
2. Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins.
Johanson K; Appelbaum E; Doyle M; Hensley P; Zhao B; Abdel-Meguid SS; Young P; Cook R; Carr S; Matico R
J Biol Chem; 1995 Apr; 270(16):9459-71. PubMed ID: 7721873
[TBL] [Abstract][Full Text] [Related]
3. Covalent modification of the interleukin-5 receptor by isothiazolones leads to inhibition of the binding of interleukin-5.
Devos R; Guisez Y; Plaetinck G; Cornelis S; Tavernier J; van der Heyden J; Foley LH; Scheffler JE
Eur J Biochem; 1994 Oct; 225(2):635-40. PubMed ID: 7957178
[TBL] [Abstract][Full Text] [Related]
4. Structure/function analysis of human interleukin 5 and its receptor.
Tavernier J; Cornelis S; Devos R; Guisez Y; Plaetinck G; Van der Heyden J
Agents Actions Suppl; 1995; 46():23-34. PubMed ID: 7610988
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the interaction between human interleukin-5 and the soluble domain of its receptor using a surface plasmon resonance biosensor.
Morton TA; Bennett DB; Appelbaum ER; Cusimano DM; Johanson KO; Matico RE; Young PR; Doyle M; Chaiken IM
J Mol Recognit; 1994 Mar; 7(1):47-55. PubMed ID: 7986567
[TBL] [Abstract][Full Text] [Related]
6. Mutants of single chain interleukin 5 show asymmetric recruitment of receptor alpha and betac subunits.
Li J; Cook R; Chaiken I
J Biol Chem; 1996 Dec; 271(49):31729-34. PubMed ID: 8940197
[TBL] [Abstract][Full Text] [Related]
7. Single chain human interleukin 5 and its asymmetric mutagenesis for mapping receptor binding sites.
Li J; Cook R; Dede K; Chaiken I
J Biol Chem; 1996 Jan; 271(4):1817-20. PubMed ID: 8567620
[TBL] [Abstract][Full Text] [Related]
8. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.
Tavernier J; Devos R; Cornelis S; Tuypens T; Van der Heyden J; Fiers W; Plaetinck G
Cell; 1991 Sep; 66(6):1175-84. PubMed ID: 1833065
[TBL] [Abstract][Full Text] [Related]
9. Kinetic characterization of the interaction of biotinylated human interleukin 5 with an Fc chimera of its receptor alpha subunit and development of an ELISA screening assay using real-time interaction biosensor analysis.
Bennett D; Morton T; Breen A; Hertzberg R; Cusimano D; Appelbaum E; McDonnell P; Young P; Matico R; Chaiken I
J Mol Recognit; 1995; 8(1-2):52-8. PubMed ID: 7598953
[TBL] [Abstract][Full Text] [Related]
10. Analysis of three human interleukin 5 structures suggests a possible receptor binding mechanism.
Verschelde JL; Ampe C; Guisez Y; Oefner C; Vandekerckhove J; Tavernier J
FEBS Lett; 1998 Mar; 424(3):121-6. PubMed ID: 9539134
[TBL] [Abstract][Full Text] [Related]
11. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation.
Plugariu CG; Wu SJ; Zhang W; Chaiken I
Biochemistry; 2000 Dec; 39(48):14939-49. PubMed ID: 11101310
[TBL] [Abstract][Full Text] [Related]
12. Biosensor analysis of dynamics of interleukin 5 receptor subunit beta(c) interaction with IL5:IL5R(alpha) complexes.
Scibek JJ; Evergren E; Zahn S; Canziani GA; Van Ryk D; Chaiken IM
Anal Biochem; 2002 Aug; 307(2):258-65. PubMed ID: 12202242
[TBL] [Abstract][Full Text] [Related]
13. Peptide insertions in domain 4 of hbeta(c), the shared signalling receptor subunit for GM-CSF, IL3 and IL5, induce ligand-independent activation.
Jones KL; Bagley CJ; Butcher C; Barry SC; Vadas MA; D'Andrea RJ
Cytokine; 2001 Jun; 14(6):303-15. PubMed ID: 11497491
[TBL] [Abstract][Full Text] [Related]
14. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation.
Graber P; Proudfoot AE; Talabot F; Bernard A; McKinnon M; Banks M; Fattah D; Solari R; Peitsch MC; Wells TN
J Biol Chem; 1995 Jun; 270(26):15762-9. PubMed ID: 7797578
[TBL] [Abstract][Full Text] [Related]
15. The cell surface expression level of the human interleukin-5 receptor alpha subunit determines the agonistic/antagonistic balance of the human interleukin-5 E13Q mutein.
Van Ostade X; Van der Heyden J; Verhee A; Vandekerckhove J; Tavernier J
Eur J Biochem; 1999 Feb; 259(3):954-60. PubMed ID: 10092887
[TBL] [Abstract][Full Text] [Related]
16. Receptor epitope usage by an interleukin-5 mimetic peptide.
Ishino T; Urbina C; Bhattacharya M; Panarello D; Chaiken I
J Biol Chem; 2005 Jun; 280(24):22951-61. PubMed ID: 15826943
[TBL] [Abstract][Full Text] [Related]
17. The solution structure of the cytokine-binding domain of the common beta-chain of the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5.
Mulhern TD; Lopez AF; D'Andrea RJ; Gaunt C; Vandeleur L; Vadas MA; Booker GW; Bagley CJ
J Mol Biol; 2000 Apr; 297(4):989-1001. PubMed ID: 10736232
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of the functional receptors for murine and human interleukin 5.
Takaki S; Murata Y; Kitamura T; Miyajima A; Tominaga A; Takatsu K
J Exp Med; 1993 Jun; 177(6):1523-9. PubMed ID: 8496674
[TBL] [Abstract][Full Text] [Related]
19. Follitropin conformational stability mediated by loop 2 beta effects follitropin-receptor interaction.
Roth KE; Dias JA
Biochemistry; 1996 Jun; 35(24):7928-35. PubMed ID: 8672495
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains.
Murphy JM; Ford SC; Olsen JE; Gustin SE; Jeffrey PD; Ollis DL; Young IG
J Biol Chem; 2004 Jun; 279(25):26500-8. PubMed ID: 15060062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
